Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104 LAVAL, Québec, May 18, 2022 (GLOBE NEWSWIRE) — Acasti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results